跳至主要内容
临床试验/ACTRN12624000284561
ACTRN12624000284561尚未招募Unknown

Pilot OVERNIGHT study: Assessing the efficacy of a nOVEl approach for impRoviNg symptoms in people with pre-chronic obstructive pulmonary disease usInG Hepa fiLTers

The University of Melbourne0 个研究点目标入组 20 人开始时间: 2024年3月20日最近更新:
适应症

试验速览

阶段
Unknown
状态
尚未招募
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Prevention
盲法
Blinded (masking used)

入排标准

年龄范围
50 Years 至 75 Years(—)
性别
All

入选标准

  • Participants will be identified as having pre-COPD based on both respiratory symptoms and lower baseline lung function. Respiratory symptoms will be identified from the ECRHS IV short survey, including questions on current wheeze, current asthma, current asthma medication, current nasal allergy, chronic cough, chronic phlegm, and use of inhaled steroid medication. Lower baseline lung function will be identified as lower 50 percentile of pre-bronchodilator FEV1/FVC using GLI equation lung function reference at ECRHS IV.

排除标准

  • Participants do not meet the spirometric criteria for COPD (post-bronchodilator FEV1/FVC <0.7) at ECRHS IV.

研究者

相似试验